Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Has RNAi Lived Up to its Promise?

Despite a slow start, RNAi has come into its own as a useful research tool, and has clear potential as a therapeutic agent

Devin Leake and Anja van Brabant Smith at Thermo Fisher Scientific Bioscience Division (June 2012)

Keywords: RNA interference (RNAi) MicroRNAs (miRNAs) Small interfering RNAs (siRNAs) Gene function studies Gene knockdown RNA-induced silencing complexes (RISCs)

    View full article    |    Back to Biopharma section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |